Available only in the US, the ExoDx Prostate Test (EPI) is a simple, non-invasive urine test that helps you and your doctor determine whether or not you need a prostate biopsy to determine your risk of prostate cancer.
Location: United States, Massachusetts, Waltham
Phone: +1 844-396-7663
Total raised: $154.6M
Investors 2
| Date | Name | Website |
| - | b2venture | b2venture.... |
| - | Forbion | forbion.co... |
Funding Rounds 5
| Date | Series | Amount | Investors |
| 31.07.2017 | Series C | $30M | - |
| 07.01.2016 | Series B | $60M | - |
| 03.09.2015 | Series B | $17.6M | - |
| 11.03.2014 | Series B | $27M | - |
| 12.05.2010 | Series A | $20M | Forbion |
Mentions in press and media 24
| Date | Title | Description | Source |
| 13.12.2021 | Bio-Techne closes Exosome Diagnostics site at IZB | Bio-Techne had bought Exosome in 2018 for up to $575 million. Now the start-up, which offers non-inv... | bio-m.org/... |
| 28.08.2017 | CareFirst BCBS, ExoDx band together on studies for diagnosti... | The HealthWorx program allows CareFirst to join forces with early stage companies such as ExoDx. Mo... | medcitynew... |
| 31.07.2017 | Exosome Diagnostics Completes $30 Million Series C Financing | Exosome Diagnostics Inc., a leader in the liquid biopsy market, today announced the close of its $30... | forbion.co... |
| 24.07.2017 | NGN Capital Joins $30M Series C for Exosome Diagnostics | Waltham, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics Inc., a leader in the liquid b... | citybizlis... |
| 24.07.2017 | Blue Ridge Capital Joins $30M Series C for Exosome Diagnosti... | Waltham, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics Inc., a leader in the liquid b... | citybizlis... |
| 24.07.2017 | Exosome Diagnostics Raises $30M Series C | Waltham, Mass., July 24, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics Inc., a leader in the liquid b... | citybizlis... |
| 21.03.2016 | Inside the race to diagnose cancer from a simple blood draw | BOSTON — It’s a medical puzzle that has snagged the attention — and the money — of Bill Gates, Jeff ... | statnews.c... |
| 03.02.2016 | Q&A: Exosome Diagnostics launches first exosomal RNA-bas... | In a phone interview, Exosome Diagnostics’ CEO John Boyce shared more about the company’s progress a... | medcitynew... |
| 10.01.2016 | The competition: Who is Illumina’s new $100M startup, Grail,... | But other companies have been touting advances in liquid biopsy screening for some time now. This is... | medcitynew... |
| 07.01.2016 | Exosome Diagnostics Closes $60M Series B Financing | Exosome Diagnostics, Inc., a Cambridge, MA-based developer of a liquid biopsy platform that enables ... | finsmes.co... |
Show more